Predictive Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Predictive Oncology has a total shareholder equity of $4.1M and total debt of $38.0K, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are $10.6M and $6.5M respectively.
Key information
0.9%
Debt to equity ratio
US$38.04k
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.20m |
| Equity | US$4.05m |
| Total liabilities | US$6.55m |
| Total assets | US$10.60m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: POAI's short term assets ($6.6M) exceed its short term liabilities ($4.5M).
Long Term Liabilities: POAI's short term assets ($6.6M) exceed its long term liabilities ($2.0M).
Debt to Equity History and Analysis
Debt Level: POAI has more cash than its total debt.
Reducing Debt: POAI's debt to equity ratio has reduced from 4398.4% to 0.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: POAI has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: POAI is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.